#USA #Clinical Trials #Conshohocken #Suvoda #Bolt Business

Suvoda Expands Patient Transport Accessibility in the EU

Suvoda, a global leader in clinical trial technology which recently merged with Greenphire, is taking significant steps to improve patient transport for clinical trial participants across the European Union. This initiative comes through a collaborative partnership with Bolt Business, an innovative mobility company in Europe, aimed at providing a more efficient and accessible transport system for patients involved in clinical studies.

In a groundbreaking move, Suvoda enables its specialists to coordinate travel arrangements via Bolt without any out-of-pocket expenses for patients. This not only alleviates the logistical hurdles and financial burden faced by participants but also ensures that clinical trial sites and sponsors can maintain patient retention, which is crucial for the success of such trials. Will Wing, Suvoda's Director of Product, Transportation Services, emphasizes the importance of reducing travel obstacles for these patients: "The complexities of healthcare journeys shouldn't be compounded by unreliable transport. Our collaboration with Bolt Business addresses this head-on, facilitating easier travel for participants and ensuring they remain engaged in their trials."

The partnership promises to deliver a reliable and cost-effective alternative to traditional transport services while maintaining high standards of data privacy and security. The aim is to enhance accessibility for a diverse range of trial populations and ensure that all patients have reliable means of transport.

Furthermore, Liam James from Bolt Business adds, "This partnership is based on our mutual commitment to eliminate barriers faced by clinical trial participants. Protonation allows patients to benefit from flexible transport options across EU markets while giving Suvoda cost control and account management support. We want to keep patients focused on their health journeys."

This collaboration underscores Suvoda's dedication to investing in comprehensive solutions that support international travel for clinical trial participants. With services extending to more than 8,400 sites across over 2,000 studies in more than 50 countries, Suvoda provides a robust transport service, enhancing patient experience while participating in clinical research.

Recently, Suvoda has successfully merged with Greenphire in March 2025, consolidating their technological capabilities for randomization, trial supply management, patient engagement, financial support, and transport solutions. The newly unified platform symbolizes a transformative approach to tackling critical challenges in clinical trials through Integrated and optimized solutions.

More about Suvoda: headquartered near Philadelphia, Suvoda operates in various global locations, including Portland, Oregon, Barcelona, Spain, Bucharest, and Iasi in Romania, and Tokyo, Japan. The company has consistently maintained high customer satisfaction ratings, surpassing the industry average among clinical trial sponsors and CROs, who choose Suvoda to assist with over 2,000 clinical trials across 95 countries. For more information, visit suvoda.com or follow Suvoda on LinkedIn for updates and insights.

Through this partnership with Bolt Business, Suvoda is not only redefining how patient transportation is managed but is also setting a new standard for accessibility in clinical trials across Europe.

Key Takeaways

• - Suvoda partners with Bolt to provide accessible transportation for clinical trial participants in the EU.
• - The partnership allows for costs to be covered by Suvoda ensuring no extra financial burden on patients.
• - Suvoda’s recent merger with Greenphire enhances their overall service offerings for clinical trials.
• - Enhanced patient experience is at the core of this transport initiative, vital for successful trial completion.